Edward White
Stock Analyst at HC Wainwright & Co.
(2.09)
# 2,694
Out of 4,784 analysts
394
Total ratings
29.19%
Success rate
-2.32%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VALN Valneva SE | Reiterates: Buy | $17 | $6.92 | +145.58% | 38 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $2.25 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $4 | $0.43 | +821.87% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.75 | - | 11 | Mar 28, 2025 | |
| NYXH Nyxoah | Maintains: Buy | $17 → $15 | $7.00 | +114.29% | 14 | Mar 26, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $3.12 | +541.03% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $0.40 | - | 12 | Mar 25, 2025 | |
| LRMR Larimar Therapeutics | Maintains: Buy | $15 → $16 | $2.12 | +656.50% | 7 | Mar 25, 2025 | |
| AURA Aura Biosciences | Maintains: Buy | $22 → $25 | $5.82 | +329.92% | 6 | Mar 25, 2025 | |
| IFRX InflaRx | Reiterates: Buy | $8 | $1.08 | +640.74% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.96 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $0.89 | +1,699.17% | 13 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.79 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 | $8.51 | +29.34% | 18 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $37.27 | +47.59% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $12.31 | +314.30% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.99 | +134.51% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $7.37 | +347.76% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $3.96 | +1,314.14% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $13.08 | +137.09% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.49 | +302.68% | 14 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.15 | +832.40% | 17 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.21 | - | 12 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.34 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $0.36 | +7,774.02% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $16.23 | +84.84% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $0.77 | +1,456.42% | 2 | Mar 6, 2018 |
Valneva SE
Mar 31, 2025
Reiterates: Buy
Price Target: $17
Current: $6.92
Upside: +145.58%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.25
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $4
Current: $0.43
Upside: +821.87%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.75
Upside: -
Nyxoah
Mar 26, 2025
Maintains: Buy
Price Target: $17 → $15
Current: $7.00
Upside: +114.29%
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $3.12
Upside: +541.03%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.40
Upside: -
Larimar Therapeutics
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $2.12
Upside: +656.50%
Aura Biosciences
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.82
Upside: +329.92%
InflaRx
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.08
Upside: +640.74%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.96
Upside: -
Mar 11, 2025
Reiterates: Buy
Price Target: $16
Current: $0.89
Upside: +1,699.17%
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.79
Upside: -
Mar 5, 2025
Downgrades: Neutral
Price Target: $11
Current: $8.51
Upside: +29.34%
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $37.27
Upside: +47.59%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $12.31
Upside: +314.30%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $2.99
Upside: +134.51%
Feb 28, 2025
Reiterates: Buy
Price Target: $33
Current: $7.37
Upside: +347.76%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $3.96
Upside: +1,314.14%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $13.08
Upside: +137.09%
Jan 29, 2025
Reiterates: Buy
Price Target: $6
Current: $1.49
Upside: +302.68%
Dec 10, 2024
Reiterates: Buy
Price Target: $20
Current: $2.15
Upside: +832.40%
Jun 4, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.21
Upside: -
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.34
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $0.36
Upside: +7,774.02%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $16.23
Upside: +84.84%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $0.77
Upside: +1,456.42%